Topoisomerase 2β Induces DNA Breaks To Regulate Human Papillomavirus Replication.


Journal

mBio
ISSN: 2150-7511
Titre abrégé: mBio
Pays: United States
ID NLM: 101519231

Informations de publication

Date de publication:
09 02 2021
Historique:
entrez: 10 2 2021
pubmed: 11 2 2021
medline: 27 8 2021
Statut: epublish

Résumé

Topoisomerases regulate higher-order chromatin structures through the transient breaking and religating of one or both strands of the phosphodiester backbone of duplex DNA. TOP2β is a type II topoisomerase that induces double-strand DNA breaks at topologically associated domains (TADS) to relieve torsional stress arising during transcription or replication. TADS are anchored by CCCTC-binding factor (CTCF) and SMC1 cohesin proteins in complexes with TOP2β. Upon DNA cleavage, a covalent intermediate DNA-TOP2β (TOP2βcc) is transiently generated to allow for strand passage. The tyrosyl-DNA phosphodiesterase TDP2 can resolve TOP2βcc, but failure to do so quickly can lead to long-lasting DNA breaks. Given the role of CTCF/SMC1 proteins in the human papillomavirus (HPV) life cycle, we investigated whether TOP2β proteins contribute to HPV pathogenesis. Our studies demonstrated that levels of both TOP2β and TDP2 were substantially increased in cells with high-risk HPV genomes, and this correlated with large amounts of DNA breaks. Knockdown of TOP2β with short hairpin RNAs (shRNAs) reduced DNA breaks by over 50% as determined through COMET assays. Furthermore, this correlated with substantially reduced formation of repair foci such as phosphorylated H2AX (γH2AX), phosphorylated CHK1 (pCHK1), and phosphorylated SMC1 (pSMC1) indicative of impaired activation of DNA damage repair pathways. Importantly, knockdown of TOP2β also blocked HPV genome replication. Our previous studies demonstrated that CTCF/SMC1 factors associate with HPV genomes at sites in the late regions of HPV31, and these correspond to regions that also bind TOP2β. This study identifies TOP2β as responsible for enhanced levels of DNA breaks in HPV-positive cells and as a regulator of viral replication.

Identifiants

pubmed: 33563836
pii: mBio.00005-21
doi: 10.1128/mBio.00005-21
pmc: PMC7885102
pii:
doi:

Substances chimiques

DNA Topoisomerases, Type II EC 5.99.1.3

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NCI NIH HHS
ID : R01 CA059655
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA142861
Pays : United States

Informations de copyright

Copyright © 2021 Kaminski et al.

Références

Genome Biol. 2016 Aug 31;17(1):182
pubmed: 27582050
Nucleic Acids Res. 2014 Sep;42(15):9612-22
pubmed: 25081205
PLoS Pathog. 2015 Apr 13;11(4):e1004763
pubmed: 25875106
Cell Rep. 2020 Feb 4;30(5):1385-1399.e7
pubmed: 32023457
PLoS One. 2013 Oct 02;8(10):e75406
pubmed: 24098381
Cell. 2017 Jul 27;170(3):507-521.e18
pubmed: 28735753
Mol Cell. 2019 Jul 25;75(2):252-266.e8
pubmed: 31202577
Indian J Med Res. 2009 Sep;130(3):209
pubmed: 19901427
Proc Natl Acad Sci U S A. 1996 Apr 2;93(7):3062-7
pubmed: 8610168
Sci Rep. 2015 Nov 02;5:15952
pubmed: 26522968
mBio. 2018 Feb 13;9(1):
pubmed: 29440569
Nat Commun. 2017 Aug 10;8(1):233
pubmed: 28794467
Mol Cell. 2007 Dec 14;28(5):739-45
pubmed: 18082599
J Virol. 2019 Mar 21;93(7):
pubmed: 30651357
Science. 1992 Aug 14;257(5072):971-3
pubmed: 1323879
Mol Cell. 2019 May 2;74(3):466-480.e4
pubmed: 30930055
Cell. 2015 Jun 18;161(7):1592-605
pubmed: 26052046
Virology. 2019 Nov;537:149-156
pubmed: 31493653
Int J Mol Sci. 2018 Sep 14;19(9):
pubmed: 30223465
Nat Commun. 2013;4:2478
pubmed: 24072229
PLoS Pathog. 2009 Oct;5(10):e1000605
pubmed: 19798429
mBio. 2019 Mar 19;10(2):
pubmed: 30890612
PLoS Biol. 2018 Oct 25;16(10):e2005752
pubmed: 30359362
mBio. 2015 Dec 22;6(6):e02006-15
pubmed: 26695634
Virology. 2016 Dec;499:383-396
pubmed: 27764728
Nat Rev Cancer. 2010 Aug;10(8):550-60
pubmed: 20592731

Auteurs

Paul Kaminski (P)

Department of Microbiology-Immunology, Northwestern University, Feinberg School of Medicine, Chicago, Illinois, USA.

Shiyuan Hong (S)

Department of Microbiology-Immunology, Northwestern University, Feinberg School of Medicine, Chicago, Illinois, USA hongshiyuan@cqmu.edu.cn l-laimins@northwestern.edu.
Institute of Life Sciences, Chongqing Medical University, Chongqing, China.

Takeyuki Kono (T)

Department of Microbiology-Immunology, Northwestern University, Feinberg School of Medicine, Chicago, Illinois, USA.

Paul Hoover (P)

Department of Microbiology-Immunology, Northwestern University, Feinberg School of Medicine, Chicago, Illinois, USA.

Laimonis Laimins (L)

Department of Microbiology-Immunology, Northwestern University, Feinberg School of Medicine, Chicago, Illinois, USA hongshiyuan@cqmu.edu.cn l-laimins@northwestern.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH